Figure 1
Age-adjusted incidence rates for 2008…
Figure 1
Age-adjusted incidence rates for 2008 to 2012 of liver and intrahepatic bile duct…
Figure 1Age-adjusted incidence rates for 2008 to 2012 of liver and intrahepatic bile duct cancer are illustrated by state for areas in the United States with high-quality incidence data. Rates are per 100,000 persons and were age-adjusted to the 2000 US standard population (19 age groups: ages <1 year, 1–4 years, 5–9 years, …, 80–84 years, ≥85 years [Census publication p25-1130; US Bureau of the Census, Current Population Reports, p25-1130. Washington, DC: US Government Printing Office; 2000]). Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results areas reported by the North American Association of Central Cancer Registries as meeting high-quality incidence data standards for the specified time. Rates from 2008 to 2012 for non-Hispanic (NH) whites, NH blacks, NH American Indians/Alaska Natives (Contract Health Services Delivery Area 2012 counties), NH Asians/Pacific Islanders, and Hispanics (48 states: Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).
Figure 2
Age-specific incidence rates from 2008…
Figure 2
Age-specific incidence rates from 2008 to 2012 of liver and intrahepatic bile duct…
Figure 2Age-specific incidence rates from 2008 to 2012 of liver and intrahepatic bile duct cancer are illustrated by race or ethnicity for areas in the United States with high-quality incidence data. Rates are per 100,000 persons and were age-adjusted to the 2000 US standard population (19 age groups: ages <1 year, 14 years, 5–9 years, …, 80–84 years, ≥85 years [Census publication p25-1130; US Bureau of the Census, Current Population Reports, p25-1130. Washington, DC: US Government Printing Office; 2000]). Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results areas reported by the North American Association of Central Cancer Registries as meeting high-quality incidence data standards for the specified time. Rates from 2008 to 2012 for non-Hispanic (NH) whites, NH blacks, NH American Indians/Alaska Natives (AI/AN) (Contract Services Delivery Area [CHSDA] 2012 counties), NH Asians/Pacific Islanders (API), and Hispanics (48 states: Alabama, Alaska, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming).
Figure 3
Cohort rate ratios (horizontal blue…
Figure 3
Cohort rate ratios (horizontal blue lines) and 95% confidence intervals (blue shading) are…
Figure 3Cohort rate ratios (horizontal blue lines) and 95% confidence intervals (blue shading) are illustrated for the incidence of liver and intrahepatic bile duct cancer by race or ethnicity relative to the experience of the 1943 reference birth cohort (Surveillance, Epidemiology, and End Results [SEER]-13 areas, 1992–2012). The vertical lines indicate a rate ratio of 1 (no difference between a select birth cohort and the reference cohort). API indicates Asian/Pacific Islander. Source: SEER-13 areas covering about 14% of the US population (Connecticut, Hawaii, Iowa, Utah, and New Mexico; the Alaska Native Tumor Registry; rural Georgia; and the metropolitan areas of San Francisco, Los Angeles, San Jose-Monterey, Detroit, Atlanta, and Seattle-Puget Sound).
Figure 4
Age-specific liver and intrahepatic bile…
Figure 4
Age-specific liver and intrahepatic bile duct cancer incidence rates are illustrated by race…
Figure 4Age-specific liver and intrahepatic bile duct cancer incidence rates are illustrated by race or ethnicity and by age and year of diagnosis in the Surveillance, Epidemiology, and End Results (SEER)-13 areas from 1992 to 2012. Rates are per 100,000 persons. API indicates Asian/Pacific Islander. Source: SEER-13 areas covering about 14% of the US population (Connecticut, Hawaii, Iowa, Utah, and New Mexico; the Alaska Native Tumor Registry; rural Georgia; and the metropolitan areas of San Francisco, Los Angeles, San Jose-Monterey, Detroit, Atlanta, and Seattle-Puget Sound).
Figure 5
Crude death rates associated with…
Figure 5
Crude death rates associated with hepatitis C virus and liver or intrahepatic bile…
Figure 5Crude death rates associated with hepatitis C virus and liver or intrahepatic bile duct cancer are illustrated among decedents aged ≥35 years according to (A) birth cohort and year and (B) birth cohort and age for the United States from 1999 to 2013. Rates are per 100,000 persons. Hepatitis C virus was defined according to the International Classification of Diseases 10th Revision (ICD-10) codes B17.1 and B18.2. Liver and intrahepatic bile duct cancers were defined by any ICD-10 code in the C22 ICD-10 category. Patients who died from liver or intrahepatic bile duct cancers had hepatitis C and liver or intrahepatic bile duct cancer listed together as any cause of death on their death certificate. Source: National Center for Health Statistics public-use data file for the total United States, 1999 to 2013.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3